[1]
“Pharmacotherapeutic follow-up to patients with Parkinson’s disease using the drugs Levodopa and Biperiden hydrochloride: Interactions in drug treatment”, RSD, vol. 11, no. 15, p. e65111536721, Nov. 2022, doi: 10.33448/rsd-v11i15.36721.